Tadmor, T., Benjamini, O., Goldschmidt, N., Kreiniz, N., Bairey, O., Harel, R., Sarid, N., Levi, T., Wolach, O. and Herishanu, Y. (2020) “Fixed-duration obinutuzumab-ibrutinib-venetoclax for Richter’s transformation: results from the phase II GIVeRS trial”, Haematologica. Pavia, Italy. doi: 10.3324/haematol.2026.300749.